BioTuesdays
Sep 28, 8:07 PM
$LNSR received a “buy” rating from Lucid Capital Markets, which initiated coverage with an
$11 price target. Shares closed at
$6.92 on September 25.
https://biotuesdays.com/2026/09/28/lucid-starts-lensar-at-buy-pt-11/
0 replies